Inventor
SAWADA YUKI
JP29 patents
⚠️ This page may combine multiple inventors who share the name “SAWADA YUKI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
FUJISAWA PHARMACEUTICAL CO
22 patentsUS6316482B1Nov 13, 2001
Benzamide derivatives having a vasopressin antagonistic activity
FUJISAWA PHARMACEUTICAL CO64 citations96
US6207693B1Mar 27, 2001
Benzamide derivatives having a vasopressin antagonistic activity
FUJISAWA PHARMACEUTICAL CO77 citations96
US5994368ANov 30, 1999
Pyridopyrimidones, quinolines and fused N-heterocycles as bradykinin antagonists
FUJISAWA PHARMACEUTICAL CO64 citations96
US5563162AOct 8, 1996
Bradykinin antagonist quinolines
FUJISAWA PHARMACEUTICAL CO55 citations96
US5708173AJan 13, 1998
Heterocyclic compounds
FUJISAWA PHARMACEUTICAL CO30 citations93
US6582351B1Jun 24, 2003
Imidazopyridinone derivatives and their use as phosphodiesterase inhibitors
FUJISAWA PHARMACEUTICAL CO33 citations92
US6384080B1May 7, 2002
Anthranilic acid derivatives as inhibitors of the cGMP-phosphodiesterase
FUJISAWA PHARMACEUTICAL CO22 citations92
US6100284AAug 8, 2000
Heterocyclic compounds as bradykinin antagonists
FUJISAWA PHARMACEUTICAL CO18 citations92
US6015818AJan 18, 2000
Quinoline derivatives as bradykinin agonists
FUJISAWA PHARMACEUTICAL CO16 citations92
US6008229ADec 28, 1999
Heterocyclic compounds as bradykinin antagonists
FUJISAWA PHARMACEUTICAL CO17 citations92
US5750699AMay 12, 1998
Method of preparing certain 3-halo-imidazopyridines
FUJISAWA PHARMACEUTICAL CO24 citations92
US5574042ANov 12, 1996
Imidazo [1,2-a] pyridines and their pharmaceutical use
FUJISAWA PHARMACEUTICAL CO41 citations92
US5354759AOct 11, 1994
Angiotenin II antagonizing heterocyclic compounds
FUJISAWA PHARMACEUTICAL CO53 citations92
US6344462B1Feb 5, 2002
Heterocyclic compounds as bradykinin antagonists
FUJISAWA PHARMACEUTICAL CO7 citations74
US6127389AOct 3, 2000
Benzimidazole derivatives as bradykinin agonists
FUJISAWA PHARMACEUTICAL CO13 citations74
US6083961AJul 4, 2000
Benzimidazole compounds as bradykinin antagonists
FUJISAWA PHARMACEUTICAL CO12 citations74
US6083959AJul 4, 2000
Quinoline derivatives, processes for their preparation and their use as medicaments
FUJISAWA PHARMACEUTICAL CO13 citations74
US5922711AJul 13, 1999
8-substituted quinazolines, quinoxalines and benzopyridazines
FUJISAWA PHARMACEUTICAL CO11 citations74
US6495542B1Dec 17, 2002
Benzamide derivatives as vasopressin antagonists
FUJISAWA PHARMACEUTICAL CO9 citations72
US6169095B1Jan 2, 2001
Bradykinin antagonist quinolines
FUJISAWA PHARMACEUTICAL CO1 citations63
US6967197B2Nov 22, 2005
Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors
FUJISAWA PHARMACEUTICAL CO5 citations61
US6194396B1Feb 27, 2001
Benzimidazole compounds as bradykinin antagonists
FUJISAWA PHARMACEUTICAL CO0 citations52
ASTELLAS PHARMA INC
7 patentsUS7465731B2Dec 16, 2008
HDAC inhibitor
ASTELLAS PHARMA INC18 citations91
US7557127B2Jul 7, 2009
HDAC inhibitor
ASTELLAS PHARMA INC8 citations83
US7153854B2Dec 26, 2006
Pyrrolopyridazine derivatives
ASTELLAS PHARMA INC12 citations83
US8367702B2Feb 5, 2013
Quinolone derivative
ASTELLAS PHARMA INC6 citations71
US7186731B2Mar 6, 2007
2-cyanopyrrolidinecarboxamide compound
ASTELLAS PHARMA INC9 citations71
US7317009B2Jan 8, 2008
Pyrrolopyridazine derivatives
ASTELLAS PHARMA INC3 citations61
US9428501B2Aug 30, 2016
Bicyclic nitrogen-containing aromatic heterocyclic amide compound
ASTELLAS PHARMA INC1 citations49